Chemed Corp. Stock
Price
Target price
€374.00
€374.00
0.000%
-
0.000%
€508.02
29.05.26 / Stuttgart Stock Exchange
WKN: A0CBF4 / Symbol: CHE / Name: Chemed / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Chemed Corp. Stock
The Chemed Corp. price is unchanged compared to yesterday.
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Chemed Corp..
With a target price of 508 € there is a positive potential of 35.83% for Chemed Corp. compared to the current price of 374.0 €.
So far the community has only identified positive things for Chemed Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Chemed Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chemed Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chemed Corp. | 0.000% | -0.532% | 3.889% | -24.597% | 2.747% | - | - |
| Davita Inc. | -0.320% | -2.601% | 29.992% | 39.107% | 72.802% | 89.031% | 65.738% |
| Select Medical Holdings | 0.720% | 0.719% | 1.449% | 10.236% | 12.000% | -44.444% | -57.831% |
| Molina Healthcare | -2.450% | -6.114% | -11.497% | -43.941% | 2.021% | -41.657% | -27.834% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2025-04-29
CHEMED CORP's Q2 2025 financial report indicates a strong financial position with significant revenue growth and healthy profitability. Key findings include:
The overall financial trend appears positive, driven by revenue growth and improving profitability.
This analysis provides a factual assessment of CHEMED CORP's financial health based on the provided Q2 2025 financial report data. Investors should consider these factors when evaluating the company's potential future performance.
Comments
Chemed (CHE) was upgraded by Wall Street Zen from "hold" to "buy".
Show more
Ratings data for CHE provided by MarketBeat
Chemed (CHE) had its price target lowered by Oppenheimer Holdings, Inc. from $580.00 to $500.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
Chemed (NYSE:CHE) had its price target lowered by analysts at Royal Bank Of Canada from $589.00 to $572.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for CHE provided by MarketBeat
News
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake
On February 12, 2026, Barington Companies Management disclosed a new position in Chemed (NYSE:CHE), acquiring 13,000 shares in an estimated $5.56 million trade.
According to an SEC filing dated
